Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stereotype Content Model

Stereotype Content Model

The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

International journal of cancer·2026

Same author

Unlocking organic phosphorus and carbon in soil aggregates under long-term P and manure inputs.

BMC plant biology·2026

Same author

Use of Leucovorin After the FDA Announcement of Its Use for Autism Spectrum Disorders.

Pediatrics·2026

Same author

Chiral Microneedle Arrays With Terahertz Chiroptical Activity With Chiral-Plasmon-Chiral-Phonon Resonance.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

Current oncology (Toronto, Ont.)·2026

Same author

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Oral oncology·2026

Search research articles

Related Experiment Video

Updated: May 3, 2026

Home-Based Monitor for Gait and Activity Analysis

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Wearable AI for on-device frailty assessment.

Kevin Albert Kasper¹, Ryan Thien¹, Tucker Stuart¹

¹Department of Biomedical Engineering, The University of Arizona, Tucson, AZ, USA.

Nature Communications

|December 19, 2025

Summary

This study introduces an edge AI wearable device for continuous health monitoring. It performs on-device analysis, enabling long-term, real-time frailty assessment without user intervention.

More Related Videos

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

Related Experiment Videos

Last Updated: May 3, 2026

Home-Based Monitor for Gait and Activity Analysis

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Author Spotlight: Innovations in iTUG Test for Enhanced Risk Assessment and Cognitive Insights

Published on: October 25, 2024

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

Area of Science:

Biomedical Engineering
Artificial Intelligence in Healthcare
Wearable Technology

Background:

Continuous wearable monitoring offers insights into chronic conditions but faces challenges with energy demands and large datasets.
Existing systems often require off-device inference, necessitating robust network infrastructure and power, limiting clinical integration.
Machine learning can condense data into actionable trends, but on-device processing is key for practical, long-term use.

Purpose of the Study:

To develop and validate an edge AI device framework for continuous, on-device biosignal analysis.
To assess the clinical utility and model stability of the framework for gait-based frailty assessment.
To demonstrate autonomous, longitudinal analysis of high-sampling-rate biosignals over extended wear periods.

Main Methods:

Integrated artificial intelligence (AI) with clinical-grade biosignal acquisition at the edge for on-device inference.
Utilized the framework for gait-based frailty assessment in vivo (N=16).
Validated clinical utility, model stability, and on-device inference through further in vivo trials (N=14) and ten-day extended wear experiments.

Main Results:

The device framework achieved clinical-grade fidelity for on-device inference over extended durations.
Gait-based frailty assessment results matched gold standard diagnostic tools.
Demonstrated continuous operation without wearer intervention and autonomous longitudinal analysis.

Conclusions:

The developed edge AI framework enables practical, long-term wearable health monitoring.
On-device inference with clinical-grade fidelity is feasible for continuous biosignal analysis.
This technology has the potential to significantly enhance diagnostic and screening tools for chronic conditions.